CAPRICOR THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Capricor Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Capricor Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13M, a 89.5% decline year-over-year.
  • Capricor Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$36.1M, a 17.1% decline year-over-year.
  • Capricor Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$24.1M, a 18.9% increase from 2022.
  • Capricor Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$29.7M, a 41.8% decline from 2021.
  • Capricor Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$20.9M, a 52.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$36.1M -$13M -$6.15M -89.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$30M -$11.6M -$3.84M -49.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$26.2M -$10.3M -$2.08M -25.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$24.1M -$1.28M +$6.79M +84.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$30.9M -$6.86M -$387K -5.97% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$30.5M -$7.75M -$426K -5.81% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$30.1M -$8.18M -$353K -4.51% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$29.7M -$8.07M -$1.69M -26.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$28M -$6.48M -$2.16M -50.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$25.8M -$7.32M -$2.24M -44% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$23.6M -$7.83M -$2.67M -51.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$20.9M -$6.38M -$2.2M -52.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 -$18.7M -$4.31M -$400K -10.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$18.3M -$5.08M -$1.6M -45.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$16.7M -$5.16M -$3.05M -145% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$13.7M -$4.18M -$2.7M -182% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$11M -$3.91M -$2.29M -140% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$8.71M -$3.49M -$1.42M -68.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$7.28M -$2.11M +$450K +17.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$7.73M -$1.48M +$1.82M +55.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$9.56M -$1.63M +$2.54M +61% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$12.1M -$2.07M +$2.1M +50.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$14.2M -$2.56M +$1.13M +30.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$15.3M -$3.31M -$25.5K -0.78% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$15.3M -$4.17M -$1.53M -58.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$13.8M -$4.16M -$784K -23.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$13M -$3.69M -$121K -3.38% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$12.9M -$3.28M -$367K -12.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$12.5M -$2.64M +$2.6M +49.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$15.1M -$3.38M +$1.23M +26.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$16.3M -$3.57M +$645K +15.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$17M -$2.91M +$372K +11.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-22
Q3 2016 -$17.3M -$5.24M -$2.39M -83.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$15M -$4.61M -$1.55M -50.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$13.4M -$4.21M -$796K -23.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$12.6M -$3.28M -$1.42M -75.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$11.2M -$2.85M -$1.37M -91.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$9.83M -$3.06M -$1.58M -107% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$8.25M -$3.41M -$2.23M -188% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$6.02M -$1.87M +$494K +20.9% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$6.51M -$1.49M +$8.96K +0.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$6.52M -$1.48M +$135K +8.34% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$6.66M -$1.19M +$247K +17.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$6.9M -$2.36M -$2.38M -11583% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$4.52M -$1.49M -$918K -159% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$3.6M -$1.62M -$841K -109% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$2.76M -$1.43M -$662K -86% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$2.1M $20.6K +$1.69M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$3.79M -$576K +$580K +50.2% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$4.37M -$774K +$106K +12% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$4.47M -$770K +$428K +35.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-06-21
Q4 2011 -$4.9M -$1.66M Oct 1, 2011 Dec 31, 2011 10-K 2013-06-21
Q3 2011 -$1.16M +$656K +36.2% Jul 1, 2011 Sep 30, 2011 10-Q 2013-06-21
Q2 2011 -$880K +$621K +41.4% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-10
Q1 2011 -$1.2M Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-05-15
Q3 2010 -$1.81M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.5M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.